Head-to-head · Value Score
bmiMD vs Medivive
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Medivive a 63. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameMedivive
#335 · Grade C · Watch List
Est. first month
From $162/mo (compounded)
Save ~88% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 63 — an est. $99/mo first month, with no teaser step-up baked in. Medivive isn't out of it: Shoppers who want all-in-one telehealth shoppers exploring compounded GLP-1 alongside TRT, NAD+ and longevity care.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | Medivive |
|---|---|---|
| Value Score | 89 (A) | 63 (C) |
| Est. first month | $99/mo | From $162/mo (compounded) |
| Save vs brand-name | ~93% | ~88% |
| Semaglutide | $99/mo | Not disclosed |
| Tirzepatide | $139/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Medivive
Medivive is a US telehealth service offering compounded semaglutide and tirzepatide for weight loss, filled through a licensed pharmacy, with providers licensed in all 50 states and no insurance required.
Why it's a deal
- Compounded semaglutide and tirzepatide with providers licensed in all 50 states
- No insurance required; one-stop for GLP-1 plus TRT, NAD+ and longevity care
- Medication filled through a licensed pharmacy
The fine print
- Monthly pricing not published; disclosed only after an AI intake
- No legal entity or named pharmacy disclosed
- Service states are not individually listed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Medivive.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.